NanoSomiX and Beckman Coulter Diagnostics Collaborate on Extracellular Vesicle-Enabled Immunoassays for Neurodegenerative Diseases

PartnershipExtracellular Vesicle-Enabled ImmunoassaysPositive

AI Analysis

Summary

NanoSomiX announced a collaboration with Beckman Coulter Diagnostics to develop extracellular vesicle-enabled immunoassays for diagnosing neurodegenerative diseases. The partnership leverages NanoSomiX's EV analytics technology combined with Beckman Coulter's clinical diagnostics expertise.

Importance:6/10

Sentiment:

0.50

extracellular vesiclesblood-based diagnosticsneurodegenerative diseasescollaborationimmunoassay

Related Companies

$GBCYD $BNN.DE

Read the original article

Published by PR Newswire Biotech on July 22, 2026 12:15 PM

Read Original